Cleveland Clinic Thyroid Expo 2026

Thyroid Cancer, Hypothyroidism, 2025 ATA Guidelines, Thyroid Ultrasound, Molecular Pathology & Thyroid Eye Disease

The Cleveland Clinic Thyroid Expo 2026 is a one-day medical education course providing evidence-based updates in the diagnosis and management of thyroid diseases, with particular emphasis on recent advances in thyroid cancer care.

Held on October 8, 2026, at the InterContinental Hotel and Conference Center in Cleveland, Ohio, the original course was offered both in person and via live stream.

Organized by Cleveland Clinic Endocrinology & Metabolism, the program features expert lectures and clinical case discussions covering primary hypothyroidism, differentiated thyroid cancer, the 2025 American Thyroid Association (ATA) Guidelines, molecular pathology, advanced thyroid cancer, external beam radiation therapy, point-of-care thyroid ultrasound, and thyroid eye disease.

The course features Matthew Ringel, MD, professor at The Ohio State University College of Medicine and co-chair of the ATA differentiated thyroid cancer guidelines task force.

Course Details

• Organizer: Cleveland Clinic
• Date: October 8, 2026
• Venue: InterContinental Hotel and Conference Center, Cleveland, Ohio
• Original Format: In-Person and Live Stream
• Original Maximum CME: 6.0 AMA PRA Category 1 Credits
• Specialties: Endocrinology, Thyroid Surgery, Oncology, Pathology and Primary Care
• Keynote Speaker: Matthew Ringel, MD
• Course Co-Directors: Ossama Lashin, MD, PhD; Joyce Shin, MD
• Language: English

Official Scientific Program

Thursday, October 8, 2026 — Eastern Time

1. Primary Hypothyroidism: Practical Treatment Decisions in Real Patients
   8:50 AM — Mary Vouyiouklis Kellis, MD
   Evidence-based hypothyroidism management, thyroid hormone replacement, and practical treatment considerations.
2. 2025 ATA Differentiated Thyroid Cancer Guidelines: Applications for Clinical Practice
   9:20 AM — Matthew Ringel, MD
   Keynote review of updated ATA recommendations, risk stratification, diagnosis, and clinical management.
3. Further De-escalation in Treatment of Differentiated Thyroid Carcinoma and the Importance of Pathology
   10:40 AM — Christopher Griffith, MD
   Risk-adapted treatment, histopathology, molecular findings, and individualized thyroid cancer care.
4. Management of Advanced Thyroid Cancer
   11:10 AM — Joseph Scharpf, MD
   Multidisciplinary management, treatment selection, and emerging approaches to advanced thyroid malignancies.
5. Integrating External Beam Radiation Therapy into Current and Emerging Paradigms in Aggressive Differentiated Thyroid Cancer
   12:40 PM — Neil Woody, MD
   Radiation therapy indications and the management of aggressive differentiated thyroid carcinoma.
6. Tips and Tricks of Point-of-Care Thyroid Ultrasound
   1:10 PM — Gustavo Romero-Velez, MD
   Practical thyroid ultrasound, real-time imaging, and clinical decision-making.
7. Medical Management of Thyroid Eye Disease: The Endocrinologist Perspective
   1:40 PM — Ossama Lashin, MD, PhD
   Thyroid eye disease pathophysiology, clinical assessment, and medical treatment.
8. Case Session / Panel Discussion
   2:40 PM — Allan Siperstein, MD
   Expert discussion of complex thyroid cases, diagnostic challenges, and therapeutic approaches.

4:15 PM — Course Adjournment

Learning Objectives

Upon completion of the original educational activity, participants should be better able to:

• Apply current guidelines for diagnosing and managing primary hypothyroidism, including patients with malabsorption.
• Interpret the 2025 ATA differentiated thyroid cancer guidelines and their implications for clinical practice.
• Incorporate pathological and molecular findings into thyroid cancer risk assessment.
• Evaluate multidisciplinary treatments, including emerging therapies for advanced thyroid cancer.
• Assess the indications and outcomes of external beam radiation therapy in aggressive thyroid malignancies.
• Recognize thyroid eye disease and review appropriate medical management.
• Utilize point-of-care thyroid ultrasound and real-time imaging in clinical decision-making.

Target Audience

• Endocrinologists
• Primary Care Physicians
• Internal Medicine Physicians
• Endocrine Surgeons
• Thyroid and Head & Neck Surgeons
• Oncologists
• Radiation Oncologists
• Pathologists
• Geneticists
• Immunologists
• Nurse Practitioners
• Physician Assistants
• Medical Residents and Fellows

Continuing Medical Education

The original Cleveland Clinic Thyroid Expo 2026 was designated for a maximum of 6.0 AMA PRA Category 1 Credits.

Official accreditation requires eligible participation through Cleveland Clinic.

Important: Separately distributed educational recordings do not automatically include CME credits, completion certificates, original conference registration, or Cleveland Clinic learning platform access.

The original registration included online faculty PowerPoint presentations in PDF format, but their inclusion in an independent digital package must be confirmed separately.

Official References

2026 Thyroid Expo – Scientific Agenda

Faculty and Course Directors

Short Description

Cleveland Clinic Thyroid Expo 2026 provides a focused, one-day review of thyroid disease management and emerging advances in thyroid cancer treatment.

Held on October 8, 2026, in Cleveland, Ohio, the original program features expert-led sessions covering:

Topics:

Thursday, October 8, 2026

All times in Eastern Time